{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:17:16Z","timestamp":1787008636057,"version":"build-2736575974"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2018,1,22]],"date-time":"2018-01-22T00:00:00Z","timestamp":1516579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/about_us\/legal\/notices"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UM1 AI068634"],"award-info":[{"award-number":["UM1 AI068634"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UM1 AI068636"],"award-info":[{"award-number":["UM1 AI068636"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UM1 AI106701"],"award-info":[{"award-number":["UM1 AI106701"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["UM1CA121947"],"award-info":[{"award-number":["UM1CA121947"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA190152"],"award-info":[{"award-number":["CA190152"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA019014"],"award-info":[{"award-number":["CA019014"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,7,2]]},"DOI":"10.1093\/cid\/ciy044","type":"journal-article","created":{"date-parts":[[2018,1,18]],"date-time":"2018-01-18T15:24:02Z","timestamp":1516289042000},"page":"251-260","source":"Crossref","is-referenced-by-count":33,"title":["As-Needed Vs Immediate Etoposide Chemotherapy in Combination With Antiretroviral Therapy for Mild-to-Moderate AIDS-Associated Kaposi Sarcoma in Resource-Limited Settings: A5264\/AMC-067 Randomized Clinical Trial"],"prefix":"10.1093","volume":"67","author":[{"given":"Mina C","family":"Hosseinipour","sequence":"first","affiliation":[{"name":"UNC Project, Lilongwe, Malawi"},{"name":"University of North Carolina School of Medicine, Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minhee","family":"Kang","sequence":"additional","affiliation":[{"name":"Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan E","family":"Krown","sequence":"additional","affiliation":[{"name":"AIDS Malignancy Consortium, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aggrey","family":"Bukuru","sequence":"additional","affiliation":[{"name":"Joint Clinical Research Center, Kampala, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Triin","family":"Umbleja","sequence":"additional","affiliation":[{"name":"Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey N","family":"Martin","sequence":"additional","affiliation":[{"name":"University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackson","family":"Orem","sequence":"additional","affiliation":[{"name":"Uganda Cancer Institute, Kampala"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Godfrey","sequence":"additional","affiliation":[{"name":"HIV Research Branch, TRP, DAIDS, NIAID, National Institutes of Health, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda","family":"Hoagland","sequence":"additional","affiliation":[{"name":"INI Evandro Chagas\/FIOCRUZ, Rio de Janiero, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noluthando","family":"Mwelase","sequence":"additional","affiliation":[{"name":"University of Witwatersrand, Johannesburg, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Langat","sequence":"additional","affiliation":[{"name":"Kenya Medical Research Institute\/Walter Reed Project, Kericho"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mulinda","family":"Nyirenda","sequence":"additional","affiliation":[{"name":"Johns Hopkins Project, University of Malawi College of Medicine, Blantyre, Malawi"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"MacRae","sequence":"additional","affiliation":[{"name":"IMPACTA Peru, Lima"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Borok","sequence":"additional","affiliation":[{"name":"AIDS Malignancy Consortium, New York, New York"},{"name":"University of Zimbabwe, Harare"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wadzanai","family":"Samaneka","sequence":"additional","affiliation":[{"name":"University of Zimbabwe, Harare"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes","family":"Moses","sequence":"additional","affiliation":[{"name":"UNC Project, Lilongwe, Malawi"},{"name":"University of North Carolina School of Medicine, Chapel Hill"},{"name":"AIDS Malignancy Consortium, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosie","family":"Mngqbisa","sequence":"additional","affiliation":[{"name":"DICRS, Enhancing Care Foundation, Durban, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naftali","family":"Busakhala","sequence":"additional","affiliation":[{"name":"Moi University, Eldoret, Kenya"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otoniel","family":"Mart\u00ednez-Maza","sequence":"additional","affiliation":[{"name":"AIDS Malignancy Consortium, New York, New York"},{"name":"University of California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Ambinder","sequence":"additional","affiliation":[{"name":"AIDS Malignancy Consortium, New York, New York"},{"name":"Johns Hopkins University, Baltimore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk P","family":"Dittmer","sequence":"additional","affiliation":[{"name":"University of North Carolina School of Medicine, Chapel Hill"},{"name":"AIDS Malignancy Consortium, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa","family":"Nokta","sequence":"additional","affiliation":[{"name":"National Cancer Institute, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas B","family":"Campbell","sequence":"additional","affiliation":[{"name":"University of Colorado School of Medicine, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"A5264\/AMC-067 REACT-KS Team","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,1,22]]},"reference":[{"key":"key\n\t\t\t\t20180702005804_CIT0001","first-page":"305","article-title":"A cluster of Kaposi\u2019s sarcoma and Pneumocystis carinii pneumonia among homosexual male residents of Los Angeles and Orange Counties, California","volume":"31","author":"Centers for Disease Control","year":"1982","journal-title":"Morb Mortal Wkly Rep"},{"key":"key\n\t\t\t\t20180702005804_CIT0002","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/cam4.618","article-title":"A prospective ascertainment of cancer incidence in sub-Saharan Africa: the case of Kaposi sarcoma","volume":"5","author":"Semeere","year":"2016","journal-title":"Cancer Med"},{"key":"key\n\t\t\t\t20180702005804_CIT0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jiph.2014.08.003","article-title":"Assessing the impact of HAART on the incidence of defining and non-defining AIDS cancers among patients with HIV\/AIDS: a systematic review","volume":"8","author":"Cobucci","year":"2015","journal-title":"J Infect Public Health"},{"key":"key\n\t\t\t\t20180702005804_CIT0004","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/QAI.0000000000000360","article-title":"Incidence rate of Kaposi sarcoma in HIV-infected patients on antiretroviral therapy in Southern Africa: a prospective multicohort study","volume":"67","author":"Rohner","year":"2014","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20180702005804_CIT0005","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1093\/cid\/ciw562","article-title":"Changing incidence and risk factors for Kaposi sarcoma by time since starting antiretroviral therapy: collaborative analysis of 21 European cohort studies","volume":"63","author":"Cancer Project Working Group for the Collaboration of Observational HIV Epidemiological Research Europe Study in EuroCoord","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180702005804_CIT0006","doi-asserted-by":"crossref","first-page":"e28691","DOI":"10.1371\/journal.pone.0028691","article-title":"Early mortality in adults initiating antiretroviral therapy (ART) in low- and middle-income countries (LMIC): a systematic review and meta-analysis","volume":"6","author":"Gupta","year":"2011","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180702005804_CIT0007","article-title":"Guidelines on the treatment of skin and oral HIV-associated conditions in children and adults","author":"World Health Organization","year":"2014"},{"key":"key\n\t\t\t\t20180702005804_CIT0008","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1086\/515593","article-title":"Trends in AIDS-related opportunistic infections among men who have sex with men and among injecting drug users, 1991\u20131996","volume":"178","author":"Jones","year":"1998","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180702005804_CIT0009","doi-asserted-by":"crossref","first-page":"F45","DOI":"10.1097\/00002030-199807000-00002","article-title":"Clinical and biological impact of antiretroviral therapy with protease inhibitors on HIV-related Kaposi\u2019s sarcoma","volume":"12","author":"Lebb\u00e9","year":"1998","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20180702005804_CIT0010","doi-asserted-by":"crossref","first-page":"19929","DOI":"10.7448\/IAS.18.1.19929","article-title":"Excellent clinical outcomes and retention in care for adults with HIV-associated Kaposi sarcoma treated with systemic chemotherapy and integrated antiretroviral therapy in rural Malawi","volume":"18","author":"Herce","year":"2015","journal-title":"J Int AIDS Soc"},{"key":"key\n\t\t\t\t20180702005804_CIT0011","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1200\/JCO.1997.15.9.3085","article-title":"AIDS-related Kaposi\u2019s sarcoma: prospective validation of the AIDS Clinical Trials Group staging classification. AIDS Clinical Trials Group Oncology Committee","volume":"15","author":"Krown","year":"1997","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20180702005804_CIT0012","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1097\/QAD.0b013e3282fc9c03","article-title":"Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era","volume":"22","author":"El Amari","year":"2008","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20180702005804_CIT0013","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/QAI.0000000000001286","article-title":"Evaluation of a predictive staging model for HIV-associated Kaposi sarcoma in Uganda","volume":"74","author":"Okuku","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20180702005804_CIT0014","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1200\/JCO.2003.10.162","article-title":"AIDS-related Kaposi\u2019s sarcoma: evaluation of potential new prognostic factors and assessment of the AIDS Clinical Trial Group staging system in the Haart era\u2013the Italian Cooperative Group on AIDS and Tumors and the Italian Cohort of Patients Naive From Antiretrovirals","volume":"21","author":"Nasti","year":"2003","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20180702005804_CIT0015","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1200\/JCO.2002.12.038","article-title":"Phase II evaluation of low-dose oral etoposide for the treatment of relapsed or progressive AIDS-related Kaposi\u2019s sarcoma: an AIDS Clinical Trials Group clinical study","volume":"20","author":"Evans","year":"2002","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20180702005804_CIT0016","first-page":"138","article-title":"Weekly oral etoposide in patients with Kaposi\u2019s sarcoma associated with human immunodeficiency virus infection: a phase I multicenter trial of the AIDS Clinical Trials Group","volume":"9","author":"Paredes","year":"1995","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"key\n\t\t\t\t20180702005804_CIT0017","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1468-3083.2011.04404.x","article-title":"Oral etoposide as first-line therapy in the treatment of patients with advanced classic Kaposi\u2019s sarcoma (CKS): a single-arm trial (oral etoposide in CKS)","volume":"27","author":"Tas","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"key\n\t\t\t\t20180702005804_CIT0018","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1200\/JCO.1989.7.9.1201","article-title":"Kaposi\u2019s sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response, and staging criteria. AIDS Clinical Trials Group Oncology Committee","volume":"7","author":"Krown","year":"1989","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20180702005804_CIT0019","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0021-9681(74)90015-0","article-title":"The randomization and stratification of patients to clinical trials","volume":"27","author":"Zelen","year":"1974","journal-title":"J Chronic Dis"},{"key":"key\n\t\t\t\t20180702005804_CIT0020","first-page":"153","article-title":"Matrix metalloproteinase inhibitor COL-3 in the treatment of AIDS-related Kaposi\u2019s sarcoma: a phase I AIDS malignancy consortium study","volume":"20","author":"Cianfrocca","year":"2002","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20180702005804_CIT0021","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1259\/0007-1285-44-526-793","article-title":"Repeated assessment of results in clinical trials of cancer treatment","volume":"44","author":"Haybittle","year":"1971","journal-title":"Br J Radiol"},{"key":"key\n\t\t\t\t20180702005804_CIT0022","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1214\/aos\/1176350951","article-title":"A class of K-Sample tests for comparing the cumulative incidence of a competing risk","volume":"16","author":"Gray","year":"1988","journal-title":"An. Stat"},{"key":"key\n\t\t\t\t20180702005804_CIT0023","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"key\n\t\t\t\t20180702005804_CIT0024","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.inhe.2010.04.001","article-title":"Risk factors for mortality in AIDS-associated Kaposi sarcoma in a primary care antiretroviral treatment program in Malawi","volume":"2","author":"Chu","year":"2010","journal-title":"Int Health"},{"key":"key\n\t\t\t\t20180702005804_CIT0025","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1758-2652-13-23","article-title":"AIDS-associated Kaposi\u2019s sarcoma is linked to advanced disease and high mortality in a primary care HIV programme in South Africa","volume":"13","author":"Chu","year":"2010","journal-title":"J Int AIDS Soc"},{"key":"key\n\t\t\t\t20180702005804_CIT0026","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1086\/654800","article-title":"Evaluation of plasma human herpesvirus 8 DNA as a marker of clinical outcomes during antiretroviral therapy for AIDS-related Kaposi sarcoma in Zimbabwe","volume":"51","author":"Borok","year":"2010","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180702005804_CIT0027","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(06)68337-2","article-title":"Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries","volume":"367","author":"Braitstein","year":"2006","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180702005804_CIT0028","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1200\/JCO.2013.51.6757","article-title":"Prospective stage-stratified approach to AIDS-related Kaposi\u2019s sarcoma","volume":"32","author":"Bower","year":"2014","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20180702005804_CIT0029","unstructured":"Martin J , Laker-OkettaM, WalusansaV, et al Randomized trial of protease inhibitor-based antiretroviral therapy for Kaposi sarcoma in Africa. 2014 Conference on Retroviruses and Opportunistic Infections. Boston, MA, 2014."},{"key":"key\n\t\t\t\t20180702005804_CIT0030","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1097\/QAD.0b013e328347f775","article-title":"Sexual behavior and HIV transmission risk of Ugandan adults taking antiretroviral therapy: 3 year follow-up","volume":"25","author":"Apondi","year":"2011","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20180702005804_CIT0031","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1097\/QAD.0000000000001606","article-title":"Risk factors for early mortality on antiretroviral therapy in advanced HIV-infected adults","volume":"31","author":"Bisson","year":"2017","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20180702005804_CIT0032","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/QAI.0b013e3181bc476f","article-title":"Predictors of immune reconstitution inflammatory syndrome-associated with Kaposi sarcoma in Mozambique: a prospective study","volume":"53","author":"Letang","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20180702005804_CIT0033","doi-asserted-by":"crossref","first-page":"e16946","DOI":"10.1371\/journal.pone.0016946","article-title":"Incidence and predictors of immune reconstitution inflammatory syndrome in a rural area of Mozambique","volume":"6","author":"Letang","year":"2011","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180702005804_CIT0034","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1097\/QAD.0b013e328360a5a1","article-title":"Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma: higher incidence and mortality in Africa than in the UK","volume":"27","author":"Letang","year":"2013","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20180702005804_CIT0035","volume-title":"AIDS-Kaposi\u2019s Sarcoma Study Changed Due to Drug Underperformance","author":"National Institutes of Health"},{"key":"key\n\t\t\t\t20180702005804_CIT0036","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1200\/JCO.1999.17.2.569","article-title":"Secondary leukemia or myelodysplastic syndrome after treatment with epipodophyllotoxins","volume":"17","author":"Smith","year":"1999","journal-title":"J Clin Oncol"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/67\/2\/251\/25103019\/ciy044.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,9]],"date-time":"2019-10-09T10:34:40Z","timestamp":1570617280000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/67\/2\/251\/4819203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,22]]},"references-count":36,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,1,22]]},"published-print":{"date-parts":[[2018,7,2]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciy044","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,7,15]]},"published":{"date-parts":[[2018,1,22]]}}}